Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -59.3% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 2.2 | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | -16.2% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-19 | 73.72 | 4.29 | 0.55p | 25.5 | n/a | n/a | n/a | 0.0% |
30-Jun-20 | 78.20 | 8.07 | 1.11p | 12.6 | 0.1 | +102% | n/a | 0.0% |
30-Jun-21 | 84.33 | 3.66 | 0.45p | 55.6 | n/a | -60% | n/a | 0.0% |
30-Jun-22 | 72.77 | (12.66) | (2.14)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-23 | 60.95 | (49.83) | (7.61)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Director Resignation | 03-Apr-2024 | 07:00 | RNS |
Interim Results for six months ended 31 Dec 2023 | 27-Mar-2024 | 07:00 | RNS |
Update on funding | 27-Mar-2024 | 07:00 | RNS |
Allergy drug firm hit by trials setback | 12-Jul-2007 | The Independent |
Need to Know: Global Business Briefing | 25-Mar-2006 | Times |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 2.85p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 6.25 |
52 Week Low | 0.88 |
Volume | 750,862 |
Shares Issued | 4,766.44m |
Market Cap | £135.84m |
RiskGrade | 268 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 3,330 @ 2.85p |
16:35 | 1,963 @ 2.85p |
16:35 | 1,367 @ 2.85p |
12:29 | 400 @ 2.80p |
12:29 | 283 @ 2.80p |
You are here: research